<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>External (formerly male) condoms</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">External (formerly male) condoms</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">External (formerly male) condoms</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lee Warner, PhD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Markus J Steiner, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katherine M Stone, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Courtney A Schreiber, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>External (formerly male) condoms are a coital-dependent barrier contraceptive that do not interfere with fertility. When used consistently and correctly, external condoms can reduce the risk of pregnancy and transmission of many sexually transmitted infections, including HIV. Appropriate counseling encourages correct condom use and minimizes difficulties.</p><p>This topic will discuss the types, patient counseling, and use of external condoms. Discussions related to internal (formerly female) condoms and contraceptive selection in general are presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5471.html" rel="external">"Internal (formerly female) condoms"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5459.html" rel="external">"Contraception: Counseling and selection"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en", "man/en", or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.</p><p class="headingAnchor" id="H2"><span class="h1">TYPES OF EXTERNAL CONDOMS</span><span class="headingEndMark"> — </span>External condoms are available in a variety of shapes, sizes, colors, and thicknesses; with or without lubricants or spermicides; and with or without reservoir tips or nipple ends [<a href="#rid1">1</a>]. They can be straight-sided or tapered toward the closed end; textured (ribbed) or smooth; solid-colored or nearly transparent; and odorless, scented, or flavored. Most are approximately 7 inches (180 mm) long, 2 inches (52 mm) wide, and up to 0.003 inches (0.08 mm) thick.</p><p class="headingAnchor" id="H3"><span class="h2">Material</span><span class="headingEndMark"> — </span>Condoms are made of latex rubber, natural membranes, or synthetic material.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rubber (latex)</strong> – Approximately 80 percent of external condoms available in the United States are manufactured from natural rubber latex [<a href="#rid2">2</a>]. They are generally less expensive than condoms made from other materials. The dual protection provided by latex condoms against unintended pregnancy, as well as many sexually transmitted infections (STIs; particularly HIV), is well documented. However, latex condoms cannot be used by persons with latex sensitivity or allergy and are not compatible with oil-based lubricants or medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural membrane</strong> – A small proportion (&lt;5 percent) of condoms are made from the intestinal cecum of lambs ("natural skin," "natural membrane," or "lambskin" condoms). While any type of lubricant can be used with these condoms, natural membrane condoms contain small pores that may permit the passage of viruses, including hepatitis B virus, herpes simplex virus, and HIV [<a href="#rid3">3,4</a>]. There are no available effectiveness data on contraceptive or STI prevention. Because these materials are porous, these condoms may not provide the same level of protection against STIs as latex condoms and should not be recommended for this purpose [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Synthetic</strong> – Polyurethane and other synthetic materials such as polyisoprene are also used to manufacture condoms and account for the remaining 15 percent of condoms. Compared with latex condoms, synthetic condoms are generally nonallergenic, compatible with both oil-based and water-based lubricants, and have a longer shelf-life [<a href="#rid6">6</a>]. The effectiveness of synthetic condoms to prevent STIs has not been well studied; however, synthetic condoms are believed to provide STI protection similar to latex condoms. For pregnancy prevention, synthetic condoms have rates of contraceptive failure comparable to latex condoms [<a href="#rid7">7-9</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Spermicide coating</span><span class="headingEndMark"> — </span>External condoms are produced with and without additional spermicidal lubricant. Condoms prelubricated with a small amount of the spermicide <a class="drug drug_general" data-topicid="10170" href="/d/drug information/10170.html" rel="external">nonoxynol-9</a> (N-9) are no more effective than other lubricated condoms, have a higher cost and shorter shelf life [<a href="#rid10">10</a>], and may cause adverse effects in users. In one study, spermicidal condom use was associated with increased risk of urinary tract infections in young female participants [<a href="#rid11">11</a>]. Given these disadvantages and the absence of any advantages of spermicidal condoms, we do not advise their use.</p><p class="headingAnchor" id="H5"><span class="h2">Quality control</span><span class="headingEndMark"> — </span>Every condom is tested electronically for holes and weak spots before it is packaged and released for sale. Samples of condoms also undergo a series of additional laboratory tests for leakage, strength, dimensional requirements, and package integrity [<a href="#rid12">12</a>]. If the sample condoms fail any of these tests, the entire lot is rejected and destroyed. A 2009 Consumer Reports Survey showed that all condoms tested met industry standards [<a href="#rid13">13</a>], and previous surveys reported that test performance did not vary with price, thickness, or country of manufacture [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H202141534"><span class="h1">MECHANISM OF ACTION</span><span class="headingEndMark"> — </span>The condom acts as a barrier by preventing direct contact with semen (and thus sperm), genital lesions, and subclinical viral shedding on the glans and shaft of the penis. It also prevents contact with penile, vaginal, or anal discharges. Condom contraceptive efficacy depends on the skill level and experience of the user [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H3383267029"><span class="h1">COUNSELING POINTS</span></p><p class="headingAnchor" id="H175230645"><span class="h2">General</span><span class="headingEndMark"> — </span>All patients should understand why condoms are recommended (protection from sexually transmitted infections [STIs] and/or pregnancy), when to use them, how to use them most effectively, how to discuss condom use with their partner(s), and how to integrate condom use into sexual activity (vaginal, anal, oral). Counseling should be adapted to each patient's needs since they may have formed their own attitudes about condom use and may have had varying experiences with condoms. Similarly, the counseling session should be tailored to each patient's risk factors and abilities [<a href="#rid1">1</a>]. As with all contraceptive counseling, patients should understand the risks and benefits of the range of contraceptive methods available. (See  <a class="medical medical_review" href="/d/html/5459.html" rel="external">"Contraception: Counseling and selection"</a>.)</p><p>Pregnant individuals at high risk of acquiring STIs should be counseled to use condoms to protect their fetus, their partner(s), and themselves. Patients who would be at high medical risk if they became pregnant should be counseled to use a highly effective contraceptive method and should understand the risk of using a less effective method, such as condoms  (<a class="graphic graphic_figure graphicRef119765" href="/d/graphic/119765.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H858017679"><span class="h2">Contraceptive efficacy</span><span class="headingEndMark"> — </span>An estimated 2 percent of users will become pregnant during the first year of perfect use (ie, consistent and correct) of the condom, and approximately 13 of every 100 users will become pregnant during the first year of typical use, which places condoms in the moderate effectiveness category  (<a class="graphic graphic_figure graphicRef119765" href="/d/graphic/119765.html" rel="external">figure 1</a>) [<a href="#rid15">15</a>]. The marked difference in contraceptive failure rates between perfect and typical use is attributable to failure to use condoms during every act of sexual intercourse and failure to use condoms correctly throughout intercourse. Individuals vary widely in their ability to use external condoms consistently and correctly. The typical-use and perfect-use effectiveness of a variety of contraceptive methods, including condoms, is shown in the table  (<a class="graphic graphic_table graphicRef120134" href="/d/graphic/120134.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H552582711"><span class="h2">Device failure (slippage and breakage)</span><span class="headingEndMark"> — </span>Condom breakage rates vary by material, product, and route of use. </p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vaginal intercourse</strong> – The majority of studies report that condoms break approximately 2 percent of the time during vaginal intercourse; a similar proportion slip off completely [<a href="#rid16">16-21</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anal intercourse</strong> – While condom breakage and slippage during anal intercourse may be slightly more likely compared with vaginal intercourse [<a href="#rid16">16,22-25</a>], one study that defined condom failure as slippage, breakage, or both reported a 0.68 percent failure rate with anal intercourse compared with 1.89 percent for vaginal intercourse [<a href="#rid16">16</a>]. </p><p></p><p class="headingAnchor" id="H4057641828"><span class="h2">Latex sensitivity or allergy</span><span class="headingEndMark"> — </span>When exposed to latex-containing products, persons sensitive or allergic to natural rubber latex may experience irritation, allergic contact dermatitis, or systemic anaphylactic symptoms [<a href="#rid26">26,27</a>]. It is estimated that 1 to 6 percent of the United States population is allergic to latex [<a href="#rid27">27</a>], but the prevalence can be much higher in certain groups, such as health care workers and patients who have repeated exposure to latex-containing medical devices (eg, surgical and examination gloves, catheters, intubation tubes, anesthesia masks, and dental dams) [<a href="#rid26">26-28</a>]. (See  <a class="medical medical_review" href="/d/html/5543.html" rel="external">"Latex allergy: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>All patients should be questioned for potential latex allergy. As an example, does the patient experience itching, rash, or wheezing after wearing latex gloves or inflating a balloon [<a href="#rid27">27,28</a>]? If latex sensitivity is suspected, the patient can be referred for allergy skin testing or offered nonlatex condoms [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/d/html/5554.html" rel="external">"Latex allergy: Management"</a> and  <a class="medical medical_review" href="/d/html/5543.html" rel="external">"Latex allergy: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>Allergic reactions that occur only after exposure to latex condoms and not after exposure to other latex-containing products may be due to brand-specific condom attributes, such as spermicides, lubricants, perfumes, local anesthetics, or other chemical agents added during the manufacturing process [<a href="#rid30">30</a>]. In these cases, we advise patients to try a different brand.</p><p class="headingAnchor" id="H1464924568"><span class="h2">Strategies for promoting effective external condom use</span><span class="headingEndMark"> — </span>The most effective approaches for improving condom use are unclear. A 2013 systematic review of behavioral interventions with an educational or counseling component to encourage or improve condom use was unable to find strong evidence of the efficacy of this approach compared with another behavioral intervention, usual care, or no intervention [<a href="#rid31">31</a>]. Educational and/or counseling programs were associated with reductions in HSV-2 incidence, syphilis incidence, and gonorrhea prevalence but no differences in pregnancy or HIV infection rates.</p><p>Although the optimal method(s) for improving condom use are not known, we discuss the following issues with our patients:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Counsel regarding correct and consistent use</strong> – Effective use of external condoms depends heavily on the skill level and experience of the user. Appropriate counseling can minimize problems with condom use [<a href="#rid32">32</a>]. Interventions promoting condom use should address user-related behaviors that result in inconsistent use, incorrect use, or nonuse.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emphasize that external condoms should be used with every coital act</strong> – Make sure patients understand that condoms are most effective when used correctly during every act of anal, vaginal, and oral intercourse [<a href="#rid33">33</a>]. Strategies that emphasize condom use for contraception in addition to disease prevention may help decrease nonuse [<a href="#rid34">34</a>]. Recommend that patients use a new condom for each act of intercourse [<a href="#rid1">1,35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Instruct the patient on use</strong> – Encourage inexperienced patients to practice using external condoms on a model of a penis or a banana. Many problems that occur during condom use can be attributed to inexperience and can be overcome with practice [<a href="#rid36">36</a>]. Users who have had negative experiences with external condoms may be at risk of discontinuing condom use altogether [<a href="#rid37">37</a>]. (See <a class="local">'Information for use'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inform the patient to use the external condom during the entire sexual act</strong> – Some users put condoms on after starting intercourse or remove condoms prior to ejaculation [<a href="#rid24">24,25,38-43</a>]. These behaviors could expose partners to risk of pregnancy or STI. Patients should be counseled to use condoms throughout intercourse, from beginning of genital contact to after ejaculation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Provide external condoms at low or no cost to encourage use</strong> – In some settings, providing patients with a large number of condoms at low or no cost increases convenience and thus may increase consistent use. Providing patients with only a few condoms is only a short-term solution for patients who find the health care system inaccessible or who find it embarrassing to return repeatedly for condoms. Selling condoms, even at a low cost, dramatically reduces the number of condoms a patient will obtain from a clinic compared with the number of free condoms the patient will take.</p><p></p><p class="headingAnchor" id="H2889668678"><span class="h2">Impact of external condom use on sexual risk taking</span><span class="headingEndMark"> — </span>Although widespread support exists for targeted interventions to encourage condom use, concerns have been raised about the potential negative consequences of condom promotion. Some interventions promoting condom use may result in risk compensation [<a href="#rid44">44,45</a>], thus facilitating the onset or frequency of high-risk sexual activity [<a href="#rid46">46,47</a>]. Few randomized controlled trials have evaluated whether such a compensation effect exists or whether it outweighs the protective effects of condom use. However, a systematic review of 174 sexual risk reduction intervention studies concluded condom-related interventions do not undermine sexual risk reduction efforts by increasing the frequency of sexual behavior [<a href="#rid48">48</a>].</p><p>Prevention of STIs through condom use and other methods is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections"</a>.)</p><p class="headingAnchor" id="H1948577315"><span class="h2">Inaccurate beliefs</span><span class="headingEndMark"> — </span>Many misunderstandings exist about condom use. We ask patients what concerns they may have and attempt to address them all. We discuss the following points about external condoms [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Do not make users sterile, impotent, or weak.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not decrease a male user's sex drive.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cannot get lost in the partner's body.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not have holes that HIV can pass through and are not laced with HIV.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not cause illness in a female partner. Exposure to semen or sperm is not needed for a female partner's good health.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not cause illness in users by making sperm "back up."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Not only for use outside of committed relationships. Condoms are also used by established couples.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not cause cancer and do not contain cancer-causing chemicals.</p><p></p><p class="headingAnchor" id="H2258162955"><span class="h1">WHY CHOOSE EXTERNAL CONDOMS?</span></p><p class="headingAnchor" id="H1927603650"><span class="h2">Advantages</span><span class="headingEndMark"> — </span>External condoms offer several contraceptive and noncontraceptive benefits to users:</p><p class="bulletIndent1"><span class="glyph">●</span>Condoms are a coital-dependent, reversible method of contraception that do not disrupt fertility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condoms provide protection against STIs during both vaginal and anal sex. (See <a class="local">'Protection from STIs'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condoms are readily accessible without a medical examination, prescription, or special fitting, and can be obtained from many sources, including drug stores, grocery stores, clinics, vending machines, gas stations, bars, and mail-order services.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condoms are among the most inexpensive and cost-effective coital-dependent contraceptives. Some programs offer them at no cost.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condoms can be easily and discretely carried.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condoms have minimal side effects since they are relatively inert and the body is exposed to them only with coitus, not at other times.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For some users, condom use may help prevent premature ejaculation.</p><p></p><p class="headingAnchor" id="H3222002723"><span class="h2">Disadvantages</span><span class="headingEndMark"> — </span>External condoms also have disadvantages that may result in inconsistent use, incorrect use, or nonuse. Allergy to latex is the only contraindication to latex condom use. (See <a class="local">'Latex sensitivity or allergy'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>Using an external condom requires partner cooperation. In some instances, male partners will not accept wearing a condom, thus making external condom use impossible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many users and their partners complain of reduced sensitivity when condoms are used during intercourse.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Foreplay is interrupted to put the external condom on, although placing the condom can be incorporated into foreplay activity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some users cannot consistently maintain an erection when wearing a condom.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some users and their partners feel embarrassed or uncomfortable when obtaining condoms or suggesting use of condoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some users have difficulty finding a condom with a proper fit, which may decrease satisfaction and increase problems such as breakage and slippage [<a href="#rid49">49-51</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Protection from STIs</span><span class="headingEndMark"> — </span>The primary noncontraceptive benefit of condom use is the protection offered against STI acquisition. Patients (male and female) benefit from external condom use (latex or synthetic), even if another contraceptive method is being used. A general consensus exists that external condoms should play a central role in any STI/HIV prevention program [<a href="#rid16">16,52</a>].</p><p>A condom placed on the penis before any genital contact and used throughout intercourse reduces the risk of partner-to-partner transmission of infectious pathogens associated with semen; penile, vaginal, cervical, and anal epithelium; and penile, vaginal, or anal discharges. Laboratory studies indicate that latex condoms provide an effective physical barrier against passage of even the smallest sexually transmitted pathogen (hepatitis B) [<a href="#rid53">53-57</a>]. The level of protection observed during actual use varies because STIs differ in their routes of transmission, infectivity, and prevalence [<a href="#rid58">58-60</a>].</p><p>External condoms greatly reduce the risk of STIs transmitted primarily to or from the penile urethra, including gonorrhea, chlamydia, trichomoniasis, hepatitis B infection, and HIV. Condoms should also reduce the risk of STIs transmitted primarily through skin or mucosal surfaces (eg, herpes simplex virus [HSV], syphilis, chancroid, and both human papillomavirus [HPV] and HPV-associated diseases) when these areas are covered by the condom. However, the protection may be less when condoms do not completely cover the entire infected area [<a href="#rid3">3,4,32,35,61,62</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>HIV</strong> – Well-designed clinical studies of HIV-discordant couples (where one partner is HIV-infected and the other is not) have reported that consistent use of latex condoms is highly effective against sexually acquired HIV infection [<a href="#rid63">63,64</a>]. One meta-analysis reported that consistent condom use reduced the risk of acquiring HIV by approximately 80 percent [<a href="#rid65">65</a>]. Across 13 cohort studies reviewed, only 11 seroconversions occurred among 587 HIV-discordant heterosexual couples reporting consistent use [<a href="#rid65">65</a>]. (See  <a class="medical medical_review" href="/d/html/16612.html" rel="external">"HIV infection: Risk factors and prevention strategies", section on 'Condom use'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other STIs</strong> – Clinical studies of effectiveness of condoms against most other STIs also suggest protection, though the level of protection observed has been inconsistent [<a href="#rid60">60-62,66-69</a>]. Much of this inconsistency can be attributed to limitations in study design [<a href="#rid38">38,60-62,69-79</a>] since the overall quality of clinical studies for these STIs is considerably weaker than for the HIV studies. Despite these limitations, studies and systematic reviews have found condom use to be associated with a reduced risk of gonorrhea, chlamydia, trichomoniasis, syphilis, genital herpes, and HPV infection [<a href="#rid60">60,66-69,80-98</a>]. By preventing STIs and their long-term sequelae, condoms also protect female fertility. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections", section on 'Male condom use'</a>.)</p><p></p><p></p><p class="headingAnchor" id="H26"><span class="h1">INFORMATION FOR USE</span></p><p class="headingAnchor" id="H1744602597"><span class="h2">Instructions</span><span class="headingEndMark"> — </span>In 2005, the World Health Organization Experts Meeting developed a Global Handbook for Family Planning Providers that provided consensus statements on five key instructions. These five messages, with minor modifications and additional explanation, follow [<a href="#rid1">1,15,32,99</a>]. In addition, sites such as the Centers for Disease Control and Prevention provide fact sheets on <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcondomeffectiveness%2Fmale-condom-use.html&amp;token=x6cgP26HJj4t0eCAKTJ%2FsmNvBor9xyvUk5bssCIDecfNiaP54V6TXgbaTIK7iuhyupfw3KeP7N7dJnvyi95%2B%2FQ%3D%3D&amp;TOPIC_ID=5463" target="_blank">external condom use</a> with drawings to help explain the text.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>First – Use a new external condom for each act of intercourse if any risk of pregnancy or sexually transmitted infections (STIs) exists.</strong></p><p></p><p class="bulletIndent1">Patients should discuss condom use with their partner before intercourse and should have an adequate supply of condoms readily available. Extra condoms will be needed if the first is damaged, torn before use, or put on incorrectly.</p><p></p><p class="bulletIndent1">The condom package should be opened carefully to avoid damaging it with fingernails, teeth, or other sharp objects. Condoms in damaged packages or that show obvious signs of deterioration (brittleness, stickiness, or discoloration) should not be used.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Second –</strong> <strong>Before any genital contact, place the external condom on the tip of the erect penis with the rolled side out.</strong></p><p></p><p class="bulletIndent1">Unrolling the condom a short distance helps to make sure the condom is being unrolled in the right direction. If the condom does not unroll easily, it is probably inside-out and should be discarded because flipping it over and using it could expose the partner to infectious organisms contained in the pre-ejaculate.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Third</strong> –<strong> Unroll the external condom all the way to the base of the erect penis.</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The condom should cover the penile glans and shaft.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adequate, appropriate lubrication (natural or synthetic) is important before intercourse to prevent irritation of the sexual partner. (See <a class="local">'Strategies for promoting effective external condom use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fourth</strong> – <strong>Immediately after ejaculation, hold the rim at the base of the external condom and withdraw the penis while it is still erect.</strong></p><p></p><p class="bulletIndent1">The condom is held firmly against the base of the penis to prevent slippage and leakage of semen while the penis is withdrawn. The condom is then inspected for evidence of breakage or leakage. We educate patients who are using external condoms as their contraceptive method about the availability of emergency contraception should leakage occur, if pregnancy is of concern. (See <a class="local">'Complications or failure'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fifth</strong> –<strong> Throw away the used external condom safely. Condoms should not be flushed down a toilet.</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Properly discard</strong> – After removing the condom, it should be checked for visible damage, and then wrapped in tissue and discarded. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Do not reuse condoms</strong> – A new condom should be used from "beginning to end" with each act of intercourse. If the condom breaks or falls off during intercourse but before ejaculation, it should be replaced with a new condom. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Change the condom with change in type of sex</strong> – New condoms should also be used for prolonged intercourse and for different types of intercourse within a single session (eg, change the condom after anal sex if vaginal sex also is planned).</p><p></p><p>If the condom breaks, falls off, leaks, is damaged, or is not used, then pregnancy and infection are possible. (See <a class="local">'Complications or failure'</a> below.)</p><p class="headingAnchor" id="H1850294886"><span class="h2">Concomitant use of lubricants and/or medications</span><span class="headingEndMark"> — </span>Water-based lubricants (eg, K-Y, Astroglide, saliva, glycerine) and most silicone-based lubricants can be used with latex condoms, but oil-based lubricants reduce latex condom integrity and may facilitate breakage [<a href="#rid100">100</a>]. Common oil-based products that should not come into contact with latex condoms include baby oil, cold creams, edible oils (olive, peanut, corn, sunflower, canola, coconut), butter, cocoa butter, margarine, whipped cream, hand and body lotions, massage oil, petroleum jelly, rubbing alcohol, suntan oil and lotions, and <a class="drug drug_general" data-topicid="10213" href="/d/drug information/10213.html" rel="external">mineral oil</a> [<a href="#rid15">15</a>].</p><p>Patients should be aware of whether the products they use (eg, lubricants, medications) that come into contact with their condoms contain oil. This cannot be determined reliably by the look, feel, or characteristics (eg, water soluble) of the product. Spermicides are water-based. Other vaginal medications, however, often contain oil-based ingredients that can damage latex condoms (eg, <a class="drug drug_general" data-topicid="9178" href="/d/drug information/9178.html" rel="external">butoconazole</a> contains <a class="drug drug_general" data-topicid="10213" href="/d/drug information/10213.html" rel="external">mineral oil</a>); therefore, patients using these medications should remain abstinent or use synthetic condoms until intravaginal medical therapy is fully completed. Oil-based products may be safely used with polyurethane and polyisoprene condoms.</p><p class="headingAnchor" id="H4080469322"><span class="h2">Complications or failure</span><span class="headingEndMark"> — </span>Although users often fear that the condom will break or fall off during use, these events are relatively uncommon. (See <a class="local">'Device failure (slippage and breakage)'</a> above.)</p><p>We advise users to have several condoms available in case a condom is torn, put on incorrectly, falls off, or repeated intercourse is desired. We also discuss treatment options the patient should be aware of in case a condom breaks, falls off, or is discovered to have a hole following intercourse, including [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency contraception</strong> – Emergency contraception can be used as a backup method against pregnancy. We discuss availability and use of emergency contraception with all of our patients who desire to avoid pregnancy. (See  <a class="medical medical_review" href="/d/html/5475.html" rel="external">"Emergency contraception"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>HIV and STI prevention</strong> – Patients who may have been exposed to HIV or STI are evaluated for possible postexposure prophylaxis against HIV and possible presumptive treatment against other STIs. (See  <a class="medical medical_review" href="/d/html/7595.html" rel="external">"Prevention of sexually transmitted infections", section on 'Antimicrobial-based prevention strategies'</a>.)</p><p></p><p>In addition, immediately gently washing the penis, vulva, anus, and adjacent areas with soap and water may help to reduce the risk of acquiring an STI, although the effectiveness of this practice has not been well studied. Inserting an applicator full of spermicide into the vagina as soon as possible may also help to prevent pregnancy. Female partners should not douche.</p><p class="headingAnchor" id="H27"><span class="h2">Storage and expiration</span><span class="headingEndMark"> — </span>External condoms should be stored in a cool and dry place, out of direct sunlight, as excessive heat will weaken latex. However, latex condoms can probably be carried, for convenience, in a wallet for up to one month [<a href="#rid101">101</a>].</p><p>Patients should check the expiration or manufacturing date on the box or individual package. Latex condoms should not be used beyond their expiration date or more than five years after the manufacturing date.</p><p class="headingAnchor" id="H3612374988"><span class="h1">MANAGING PROBLEMS</span><span class="headingEndMark"> — </span>Routine follow-up is not required to monitor external condom use. However, we encourage patients to return any time they experience difficulties with condom use or if they desire further education. The World Health Organization also advises clinicians to ask patients about their experiences and satisfaction with condom use at any visit [<a href="#rid15">15</a>]. Possible questions include:</p><p class="bulletIndent1"><span class="glyph">●</span>Is the patient satisfied with the method? Is there anything the patient would like to discuss?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is the patient having difficulty using condoms correctly every time they have sex?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have any medical (eg, diabetes) or life changes (eg, desire for pregnancy) occurred that may impact condom use?</p><p></p><p class="headingAnchor" id="H3946246075"><span class="h1">RESOURCES FOR PATIENTS AND CLINICIANS</span><span class="headingEndMark"> — </span>Additional information about external condoms and other contraceptive options can be found at the following sites:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F260156%2F9780999203705-eng.pdf%3Bjsessionid%3DCA20D4778FC6BD9ACCE5778E3AB9E34A%3Fsequence%3D1&amp;token=kvWLQtd1stW5Ltu16rhkjksfur0T%2F0mLJC%2BTD94I8w3mREINgC8YF4ttJI1J8FsUJ3ek9%2BiJ%2Bw54G2AKQQCKG%2Flt%2BRCFFAZ8KWaUb47Bs2eMF0OPfllHsg5FZiOv209nzsgLuVq2lPzH31o6i8Lt36ecH%2FlM%2B78Odic8tFyV7%2FE%3D&amp;TOPIC_ID=5463" target="_blank">World Health Organization Family Planning Global Handbook for Providers, 2018</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fbedsider.org%2F&amp;token=zJ5gQ3rEz%2FWfF96g4EN6dZ0WWANDd0amr7%2FGWBeQMYA%3D&amp;TOPIC_ID=5463" target="_blank">Bedsider.org</a> – A free website developed by the National Campaign to Prevent Teen and Unplanned Pregnancy, a private nonprofit group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.plannedparenthood.org%2F&amp;token=xXI%2By9QNEPjV52%2B%2BDeHAeZ9SXc2ukqt22nAmmnoIhbmjKCcbIKeiWKTXDj94bQ%2F4&amp;TOPIC_ID=5463" target="_blank">Planned Parenthood</a> – A nonprofit organization dedicated to reproductive health with resources for patients and clinicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.choiceproject.wustl.edu%2F&amp;token=%2BnVJmPhZ7CoZ6P5TTscsQMEfRjhRSH%2BHYjLFHmNv8MpZBNOY80TFEfWmQJ4v5GVF&amp;TOPIC_ID=5463" target="_blank">CHOICE Project</a> – A free website sponsored by the Washington University School of Medicine in St. Louis that provides resources on contraceptive options and training resources for clinicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fyoungwomenshealth.org%2F&amp;token=4ZVQuaw7JPQhsSQn2msmz4V2t0hJWr2nmfMP%2FLbrjZq3BOM8pXRApS0zZOoQmNVZ&amp;TOPIC_ID=5463" target="_blank">Center for Young Women's Health</a> – A free website run by Boston Children's Hospital that addresses reproductive health needs of teens and young adults.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fbeyondthepill.ucsf.edu%2F&amp;token=E0Md379RCit4rTlR7PWLpRnWL3ZQCq5b3lbJ0%2FB1dPyBLwfyex9AzfdZhbKHBc6o&amp;TOPIC_ID=5463" target="_blank">Beyond the Pill</a> – A free website run by the University of California San Francisco.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.sexandu.ca%2F&amp;token=vdCs7dqmABYrTYLl86e3UBvZDVaCgDBYOgHXgKrHwtk%3D&amp;TOPIC_ID=5463" target="_blank">SexandU.ca</a> – An educational site run by the Society of Obstetricians and Gynaecologists of Canada that includes descriptions of various methods and a tool to help with selection of birth control.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.arhp.org%2Ftopics%2Fcontraception&amp;token=j%2BtF41plvYHq0KcVLVNCgv%2FJXiQRyAuQe%2B3DzcOrPcP9q%2F7MIFkACucw9pulv9nTUVKCe%2BsvwbVTUcLUbOi%2FdA%3D%3D&amp;TOPIC_ID=5463" target="_blank">Association of Reproductive Health Professionals</a> – A nonprofit organization that provides resources for patients including an interactive tool to compare birth control methods.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=http%3A%2F%2Fcdc.gov%2F&amp;token=hAxt6yeyJ1OgkFCQKrFZGaLjABAVvs%2FRhN9t7du7ajU%3D&amp;TOPIC_ID=5463" target="_blank">US Centers for Disease Control and Prevention (CDC)</a> </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2FPatients&amp;token=IQxLzDq4doJGUgaZgeIY0609e6kP88t%2BkfEnsFxRTPcTSb1%2BMcd%2F6nq0xBC60AQD&amp;TOPIC_ID=5463" target="_blank">ACOG Contraceptive FAQs</a> – American College of Obstetricians and Gynecologists addresses frequently asked questions (FAQs) about contraception.</p><p></p><p class="headingAnchor" id="H147096458"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112268.html" rel="external">"Society guideline links: Contraception"</a>.)</p><p class="headingAnchor" id="H28"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/132033.html" rel="external">"Patient education: Barrier methods of birth control (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/8422.html" rel="external">"Patient education: Barrier and pericoital methods of birth control (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H29"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Condom materials and types</strong> – Condoms are made of latex rubber, natural membranes, or synthetic material. (See <a class="local">'Material'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Latex (rubber)</strong> – Latex accounts for approximately 80 percent of external (formerly male) condoms and has the advantages of low cost and protection from sexually transmitted infections (STIs; including HIV), as well as pregnancy, but can be damaged by oil-based lubricants. </p><p></p><p class="bulletIndent2">We advise latex condoms for all patients who may be at risk for or are concerned about STI (including HIV) acquisition/transmission or pregnancy prevention. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Natural membrane</strong> – Natural membrane condoms are made from the intestinal cecum of lambs and contain small pores that may permit the passage of viruses; therefore, they are not recommended for STI prevention. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Synthetic</strong> – Synthetic condoms provide an option for people who are allergic or sensitive to latex and should provide similar protection against pregnancy and STIs as latex condoms. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Spermicide-coated condoms</strong> – We do not advise use of spermicide-coated condoms because they are no more effective than other lubricated condoms, have a higher cost and shorter shelf-life, and may cause adverse effects in users. (See <a class="local">'Spermicide coating'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – Condoms provide protection from STIs, including HIV, and/or pregnancy. Counseling of patients includes when to use condoms, how to use them most effectively, how to discuss condom use with their partner(s), and how to integrate condom use into intercourse. (See <a class="local">'General'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanism and efficacy</strong> – The condom acts as a barrier by preventing direct contact with semen (and thus sperm), genital lesions, and subclinical viral shedding on the glans and shaft of the penis. It also prevents contact with penile, vaginal, or anal discharges. Condom effectiveness depends on the motivation, skill level, and experience of the user. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Unintended pregnancy</strong> – It is estimated that 2 percent of female partners will become pregnant during the first year of perfect (ie, consistent and correct) use of the condom, and approximately 13 percent of female partners will become pregnant during the first year of typical use. (See <a class="local">'Mechanism of action'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Condom slippage and/or breakage</strong> – Condom slippage and breakage rates vary by material, product, route of use, and experience of the user. While reported rates vary, condom failure occurs with approximately 2 percent of vaginal intercourse events and with &lt;1 percent of anal intercourse events. (See <a class="local">'Device failure (slippage and breakage)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advantages, disadvantages, and contraindication</strong> – Benefits of external condoms include protection against pregnancy and STIs as well as noncontraceptive benefits. The main disadvantage is that external condom use requires partner cooperation. The only contraindication to external condom use is latex allergy. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Why choose external condoms?'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Latex sensitivity or allergy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Instructions for use</strong> – Appropriate counseling and instruction can minimize problems with condom use. The most critical factors for protection from unintended pregnancy and STIs are that a new condom is placed on the penis before any genital contact, remains intact until the penis is withdrawn, and is used with every act of intercourse. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Strategies for promoting effective external condom use'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Information for use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of lubricants</strong> – Water-based lubricants (eg, K-Y, Astroglide, saliva, glycerine) and most silicone-based lubricants can be used with latex condoms, but oil-based lubricants reduce latex condom integrity and may facilitate breakage. (See <a class="local">'Concomitant use of lubricants and/or medications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of emergency contraception</strong> – Although users often fear that the external condom will break or fall off during use, these events are relatively uncommon. In the event of condom slippage or breakage, patients should be offered emergency contraception and/or postexposure prophylaxis for STIs. (See <a class="local">'Complications or failure'</a> above.)</p><p></p><p class="headingAnchor" id="H3371017512"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Willard Cates, Jr, MD, MPH, who contributed to an earlier version of this topic review.</p><p>The findings and conclusions in this topic review are those of the authors and do not necessarily represent the views of the United States Agency for International Development, National Institutes of Health, or Centers for Disease Control and Prevention.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Warner L, Steiner MJ. Male Condoms. In: Contraceptive Technology, 21st ed, Hatcher RA, Trussell J, Nelson AL, et al (Eds), Ardent Media, New York 2018.</li><li class="breakAll">Global Industry Analysts, Inc. Condoms: A global business strategic report. San Jose, CA, March 2008, Publication #MCP-3209.</li><li><a class="nounderline abstract_t">Carey RF, Lytle CD, Cyr WH. Implications of laboratory tests of condom integrity. Sex Transm Dis 1999; 26:216.</a></li><li><a class="nounderline abstract_t">Lytle CD, Routson LB, Seaborn GB, et al. An in vitro evaluation of condoms as barriers to a small virus. Sex Transm Dis 1997; 24:161.</a></li><li class="breakAll">Consumer's Union. Condoms get better: tests of 30 models show far fewer failures than in past years. Consumer Reports. June, 1999.</li><li><a class="nounderline abstract_t">Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2006; :CD003550.</a></li><li><a class="nounderline abstract_t">Steiner MJ, Dominik R, Rountree RW, et al. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial. Obstet Gynecol 2003; 101:539.</a></li><li><a class="nounderline abstract_t">Frezieres RG, Walsh TL, Nelson AL, et al. Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial. Fam Plann Perspect 1999; 31:81.</a></li><li><a class="nounderline abstract_t">Walsh TL, Frezieres RG, Peacock K, et al. Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial. Perspect Sex Reprod Health 2003; 35:79.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Nonoxynol-9 spermicide contraception use--United States, 1999. MMWR Morb Mortal Wkly Rep 2002; 51:389.</a></li><li><a class="nounderline abstract_t">Fihn SD, Boyko EJ, Normand EH, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol 1996; 144:512.</a></li><li class="breakAll">ASTM (American Society for Testing Materials). Annual book of ASTM standards: Easton MD: ASTM: section 9, rubber. Volume 09.02 Rubber products; standard specifications for rubber contraceptives (male, American Society for Testing Materials, West Conshohocken, PA 1996.</li><li class="breakAll">Consumers Union. More reliable condoms. Consumer Reports 2009; December.</li><li class="breakAll">Consumer Union: Condoms: Extra protection. Consumer Reports 2005; February.</li><li class="breakAll">Family Planning: A Global Handbook for Providers (2018 update), 3, World Health Organization Department of Reproductive Health and Research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health/Center for Communications Programs (CCP) (Eds), CCP and WHO, Baltimore and Geneva 2018.</li><li class="breakAll">FDA Permits Marketing of First Condom Specifically Indicated for Anal Intercourse. FDA News Release.US Food and Drug Administration. February 2022. da.gov/news-events/press-announcements/fda-permits-marketing-first-condom-specifically-indicated-anal-intercourse (Accessed on February 24, 2022).</li><li><a class="nounderline abstract_t">Albert AE, Warner DL, Hatcher RA, et al. Condom use among female commercial sex workers in Nevada's legal brothels. Am J Public Health 1995; 85:1514.</a></li><li><a class="nounderline abstract_t">Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ.on plastic condom and a latex condom. Contraception 2001; 63:25.</a></li><li><a class="nounderline abstract_t">Valappil T, Kelaghan J, Macaluso M, et al. Female condom and male condom failure among women at high risk of sexually transmitted diseases. Sex Transm Dis 2005; 32:35.</a></li><li><a class="nounderline abstract_t">Macaluso M, Kelaghan J, Artz L, et al. Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis 1999; 26:450.</a></li><li><a class="nounderline abstract_t">Walsh TL, Frezieres RG, Peacock K, et al. Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception 2004; 70:407.</a></li><li><a class="nounderline abstract_t">Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse. A review. Sex Transm Dis 1997; 24:11.</a></li><li class="breakAll">Richters J, Kippax S. Condoms for anal sex. In: Condoms, 1st ed, Mindel A (Ed), BMJ Publishing Group, London 2000. p.132.</li><li><a class="nounderline abstract_t">Hernández-Romieu AC, Siegler AJ, Sullivan PS, et al. How often do condoms fail? A cross-sectional study exploring incomplete use of condoms, condom failures and other condom problems among black and white MSM in southern U.S.A. Sex Transm Infect 2014; 90:602.</a></li><li><a class="nounderline abstract_t">D'Anna LH, Margolis AD, Warner L, et al. Condom use problems during anal sex among men who have sex with men (MSM): findings from the Safe in the City study. AIDS Care 2012; 24:1028.</a></li><li><a class="nounderline abstract_t">Zaza S, Reeder JM, Charles LE, Jarvis WR. Latex sensitivity among perioperative nurses. AORN J 1994; 60:806.</a></li><li class="breakAll">National Institute for Occupational Safety and Health. Preventing allergic reactions to natural rubber latex in the workplace [NIOSH alert]. National Institute for Occupational Safety and Health, June 1997 [DHHS (NIOSH) publication No. 97-135].</li><li class="breakAll">Food and Drug Administration. Allergic reactions to latex-containing medical devices [press release]. Rockville MD; Food and Drug Administration, March 29, 1991.</li><li><a class="nounderline abstract_t">Yassin MS, Lierl MB, Fischer TJ, et al. Latex allergy in hospital employees. Ann Allergy 1994; 72:245.</a></li><li><a class="nounderline abstract_t">Hamann CP, Kick SA. Update: immediate and delayed hypersensitivity to natural rubber latex. Cutis 1993; 52:307.</a></li><li><a class="nounderline abstract_t">Lopez LM, Otterness C, Chen M, et al. Behavioral interventions for improving condom use for dual protection. Cochrane Database Syst Rev 2013; :CD010662.</a></li><li class="breakAll">Steiner MJ, Warner L, Stone KM, Cates W Jr. Condoms and other barrier methods for prevention of STI/HIV infection, and pregnancy. In: Sexually Transmitted Diseases, 4th ed, Holmes KK, Sparling PF, Mardh PA (Eds), McGraw-Hill, New York 2008.</li><li><a class="nounderline abstract_t">Steiner MJ, Cates W Jr, Warner L. The real problem with male condoms is nonuse. Sex Transm Dis 1999; 26:459.</a></li><li><a class="nounderline abstract_t">Cates W Jr, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis 2002; 29:168.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.</a></li><li><a class="nounderline abstract_t">Steiner M, Piedrahita C, Glover L, Joanis C. Can condom users likely to experience condom failure be identified? Fam Plann Perspect 1993; 25:220.</a></li><li><a class="nounderline abstract_t">Norris AE, Ford K. Associations between condom experiences and beliefs, intentions, and use in a sample of urban, low-income, African-American and Hispanic youth. AIDS Educ Prev 1994; 6:27.</a></li><li><a class="nounderline abstract_t">Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices. Implications for evaluating method and user effectiveness. Sex Transm Dis 1998; 25:273.</a></li><li><a class="nounderline abstract_t">Paz-Bailey G, Koumans EH, Sternberg M, et al. The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med 2005; 159:536.</a></li><li><a class="nounderline abstract_t">Fishbein M, Pequegnat W. Evaluating AIDS prevention interventions using behavioral and biological outcome measures. Sex Transm Dis 2000; 27:101.</a></li><li><a class="nounderline abstract_t">Calzavara L, Burchell AN, Remis RS, et al. Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol 2003; 157:210.</a></li><li><a class="nounderline abstract_t">Crosby RA, Sanders SA, Yarber WL, et al. Condom use errors and problems among college men. Sex Transm Dis 2002; 29:552.</a></li><li><a class="nounderline abstract_t">DʼAnna LH, Korosteleva O, Warner L, et al. Factors associated with condom use problems during vaginal sex with main and non-main partners. Sex Transm Dis 2012; 39:687.</a></li><li><a class="nounderline abstract_t">Richens J, Imrie J, Copas A. Condoms and seat belts: the parallels and the lessons. Lancet 2000; 355:400.</a></li><li><a class="nounderline abstract_t">Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ 2006; 332:605.</a></li><li><a class="nounderline abstract_t">Kajubi P, Kamya MR, Kamya S, et al. Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda. J Acquir Immune Defic Syndr 2005; 40:77.</a></li><li><a class="nounderline abstract_t">Imrie J, Stephenson JM, Cowan FM, et al. A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ 2001; 322:1451.</a></li><li><a class="nounderline abstract_t">Smoak ND, Scott-Sheldon LA, Johnson BT, Carey MP. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. J Acquir Immune Defic Syndr 2006; 41:374.</a></li><li><a class="nounderline abstract_t">Cecil M, Nelson AL, Trussell J, Hatcher R. If the condom doesn't fit, you must resize it. Contraception 2010; 82:489.</a></li><li><a class="nounderline abstract_t">Reece M, Herbenick D, Dodge B. Penile dimensions and men's perceptions of condom fit and feel. Sex Transm Infect 2009; 85:127.</a></li><li><a class="nounderline abstract_t">Smith AM, Jolley D, Hocking J, et al. Factors affecting men's liking of condoms they have used. Int J STD AIDS 1999; 10:258.</a></li><li><a class="nounderline abstract_t">Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground on preventing sexual transmission of HIV. Lancet 2004; 364:1913.</a></li><li><a class="nounderline abstract_t">Conant MA, Spicer DW, Smith CD. Herpes simplex virus transmission: condom studies. Sex Transm Dis 1984; 11:94.</a></li><li><a class="nounderline abstract_t">Katznelson S, Drew WL, Mintz L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis 1984; 150:155.</a></li><li><a class="nounderline abstract_t">Rietmeijer CA, Krebs JW, Feorino PM, Judson FN. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 1988; 259:1851.</a></li><li><a class="nounderline abstract_t">Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS 1987; 1:49.</a></li><li><a class="nounderline abstract_t">Judson FN, Ehret JM, Bodin GF, et al. In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis 1989; 16:51.</a></li><li><a class="nounderline abstract_t">Cates W Jr. The condom forgiveness factor: the positive spin. Sex Transm Dis 2002; 29:350.</a></li><li><a class="nounderline abstract_t">Mann JR, Stine CC, Vessey J. The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom. Sex Transm Dis 2002; 29:344.</a></li><li><a class="nounderline abstract_t">Warner L, Stone KM, Macaluso M, et al. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33:36.</a></li><li class="breakAll">National Institute of Allergy and Infectious Diseases. Workshop Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Diseases (STI) Prevention. July 20, 2001. http://www.niaid.nih.gov/dmid/STIs/condomreport.pdf. (Accessed on May 04, 2007).</li><li class="breakAll">Stone KM, Thomas E, Timyan J. Barrier methods for the prevention of sexually transmitted diseases. In: Sexually Transmitted Diseases, 3rd ed, Holmes KK, Sparling PF, Mardh PA (Eds), McGraw-Hill, New York 1998.</li><li><a class="nounderline abstract_t">Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31:272.</a></li><li><a class="nounderline abstract_t">Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; :CD003255.</a></li><li><a class="nounderline abstract_t">Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2001; :CD003255.</a></li><li><a class="nounderline abstract_t">d'Oro LC, Parazzini F, Naldi L, La Vecchia C. Barrier methods of contraception, spermicides, and sexually transmitted diseases: A review. Genitourin Med 1994; 70:410.</a></li><li><a class="nounderline abstract_t">Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29:725.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Report to Congress: prevention of genital human papillomavirus infection, January 2004.</li><li><a class="nounderline abstract_t">Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82:454.</a></li><li><a class="nounderline abstract_t">Aral SO, Peterman TA. Measuring outcomes of behavioural interventions for STD/HIV prevention. Int J STD AIDS 1996; 7 Suppl 2:30.</a></li><li><a class="nounderline abstract_t">Crosby R, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002; 78:228.</a></li><li><a class="nounderline abstract_t">Devine OJ, Aral SO. The impact of inaccurate reporting of condom use and imperfect diagnosis of sexually transmitted disease infection in studies of condom effectiveness: a simulation-based assessment. Sex Transm Dis 2004; 31:588.</a></li><li><a class="nounderline abstract_t">Steiner MJ, Feldblum PJ, Padian N. Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol 2003; 157:298.</a></li><li><a class="nounderline abstract_t">Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161:765.</a></li><li><a class="nounderline abstract_t">Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159:242.</a></li><li><a class="nounderline abstract_t">Warner L, Macaluso M, Newman D, et al. Condom effectiveness for prevention of C trachomatis infection. Sex Transm Infect 2006; 82:265.</a></li><li><a class="nounderline abstract_t">Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis 1995; 22:15.</a></li><li><a class="nounderline abstract_t">Hariri S, Warner L. Condom use and human papillomavirus in men. J Infect Dis 2013; 208:367.</a></li><li><a class="nounderline abstract_t">Crosby RA, Charnigo RA, Weathers C, et al. Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect 2012; 88:484.</a></li><li class="breakAll">Winer, RL, Hughes, JP, Feng, Q, et al. The effect of consistent condom use on the risk of genital HPV infection among newly sexually active young women. International Society for STI Research, Abstract Nr. MP-120, Amsterdam, July 2005.</li><li><a class="nounderline abstract_t">Casper C, Wald A. Condom use and the prevention of genital herpes acquisition. Herpes 2002; 9:10.</a></li><li><a class="nounderline abstract_t">Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707.</a></li><li><a class="nounderline abstract_t">Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100.</a></li><li><a class="nounderline abstract_t">Barlow D. The condom and gonorrhoea. Lancet 1977; 2:811.</a></li><li><a class="nounderline abstract_t">Ramstedt K, Forssman L, Giesecke J, Granath F. Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics. Int J STD AIDS 1992; 3:117.</a></li><li><a class="nounderline abstract_t">Upchurch DM, Brady WE, Reichart CA, Hook EW 3rd. Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic. J Infect Dis 1990; 161:938.</a></li><li><a class="nounderline abstract_t">Fennema JS, van Ameijden EJ, Coutinho RA, Van den Hoek A. Clinical sexually transmitted diseases among human immunodeficiency virus-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994. Sex Transm Dis 1997; 24:363.</a></li><li><a class="nounderline abstract_t">Levine WC, Revollo R, Kaune V, et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS 1998; 12:1899.</a></li><li><a class="nounderline abstract_t">Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978; 108:136.</a></li><li><a class="nounderline abstract_t">Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001; 185:380.</a></li><li><a class="nounderline abstract_t">Cates WC Jr, Holmes KK. Re: Condom efficacy against gonorrhea and nongonococcal urethritis. Am J Epidemiol 1996; 143:843.</a></li><li><a class="nounderline abstract_t">Sánchez J, Gotuzzo E, Escamilla J, et al. Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program. Sex Transm Dis 1998; 25:82.</a></li><li><a class="nounderline abstract_t">Schwartz MA, Lafferty WE, Hughes JP, Handsfield HH. Risk factors for urethritis in heterosexual men. The role of fellatio and other sexual practices. Sex Transm Dis 1997; 24:449.</a></li><li><a class="nounderline abstract_t">Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003; 107:811.</a></li><li><a class="nounderline abstract_t">Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003; 107:804.</a></li><li><a class="nounderline abstract_t">Alfonsi, GA, Shlay, J. The effectiveness of condoms for the prevention of sexually transmitted diseases. Current Women's Health Reviews 2005; 1:151.</a></li><li><a class="nounderline abstract_t">Koss CA, Dunne EF, Warner L. A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sex Transm Dis 2009; 36:401.</a></li><li><a class="nounderline abstract_t">Pierce Campbell CM, Lin HY, Fulp W, et al. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis 2013; 208:373.</a></li><li class="breakAll">World Health Organization Department of Reproductive Health and Research and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs, INFO Project. Family Planning: A Global Handbook for Providers. Baltimore and Geneva: CCP and WHO, 2007.</li><li><a class="nounderline abstract_t">Voeller B, Coulson AH, Bernstein GS, Nakamura RM. Mineral oil lubricants cause rapid deterioration of latex condoms. Contraception 1989; 39:95.</a></li><li class="breakAll">Glasser, G, Hatcher, RA. The effect on condom integrity of carrying a condom in a wallet for three months [abstract]. Proceedings of the American College of Obstetricians and Gynecologists District IV Conference, November 1992. San Juan PR.</li></ol></div><div id="topicVersionRevision">Topic 5463 Version 38.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Warner L, Steiner MJ. Male Condoms. In: Contraceptive Technology, 21st ed, Hatcher RA, Trussell J, Nelson AL, et al (Eds), Ardent Media, New York 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global Industry Analysts, Inc. Condoms: A global business strategic report. San Jose, CA, March 2008, Publication #MCP-3209.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10225589" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Implications of laboratory tests of condom integrity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9132983" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : An in vitro evaluation of condoms as barriers to a small virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9132983" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An in vitro evaluation of condoms as barriers to a small virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16437459" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Non-latex versus latex male condoms for contraception.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12636960" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10224546" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12729137" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12018794" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Nonoxynol-9 spermicide contraception use--United States, 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781467" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7485663" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Condom use among female commercial sex workers in Nevada's legal brothels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11257245" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Randomized crossover trial comparing the eZ.on plastic condom and a latex condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15614119" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Female condom and male condom failure among women at high risk of sexually transmitted diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10494936" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Mechanical failure of the latex condom in a cohort of women at high STD risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15504381" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9018778" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Use and effectiveness of condoms during anal intercourse. A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9018778" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Use and effectiveness of condoms during anal intercourse. A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25080511" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : How often do condoms fail? A cross-sectional study exploring incomplete use of condoms, condom failures and other condom problems among black and white MSM in southern U.S.A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22519680" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Condom use problems during anal sex among men who have sex with men (MSM): findings from the Safe in the City study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7826050" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Latex sensitivity among perioperative nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7826050" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Latex sensitivity among perioperative nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7826050" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Latex sensitivity among perioperative nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8129217" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Latex allergy in hospital employees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8299394" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Update: immediate and delayed hypersensitivity to natural rubber latex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24163112" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Behavioral interventions for improving condom use for dual protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24163112" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Behavioral interventions for improving condom use for dual protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10494937" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The real problem with male condoms is nonuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11875378" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26042815" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Sexually transmitted diseases treatment guidelines, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8262171" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Can condom users likely to experience condom failure be identified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8024941" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Associations between condom experiences and beliefs, intentions, and use in a sample of urban, low-income, African-American and Hispanic youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9662759" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Assessing condom use practices. Implications for evaluating method and user effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15939852" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10676977" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Evaluating AIDS prevention interventions using behavioral and biological outcome measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12543620" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12218848" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Condom use errors and problems among college men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22895490" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Factors associated with condom use problems during vaginal sex with main and non-main partners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10665571" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Condoms and seat belts: the parallels and the lessons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16528088" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk compensation: the Achilles' heel of innovations in HIV prevention?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16123686" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11408300" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16540941" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21074009" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : If the condom doesn't fit, you must resize it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19074183" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Penile dimensions and men's perceptions of condom fit and feel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12035780" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Factors affecting men's liking of condoms they have used.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15566989" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The time has come for common ground on preventing sexual transmission of HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6087482" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Herpes simplex virus transmission: condom studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6086770" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Efficacy of the condom as a barrier to the transmission of cytomegalovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2830416" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Condoms as physical and chemical barriers against human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3122790" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2545003" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12035025" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The condom forgiveness factor: the positive spin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12035024" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The role of disease-specific infectivity and number of disease exposures on long-term effectiveness of the latex condom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16385221" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16385221" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16385221" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10614517" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The effectiveness of condoms in reducing heterosexual transmission of HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869658" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Condom effectiveness in reducing heterosexual HIV transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11687062" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Condom effectiveness in reducing heterosexual HIV transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7705860" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Barrier methods of contraception, spermicides, and sexually transmitted diseases: A review</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12438912" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12438912" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15356939" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effectiveness of condoms in preventing sexually transmitted infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8799792" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Measuring outcomes of behavioural interventions for STD/HIV prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12181456" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15388995" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The impact of inaccurate reporting of condom use and imperfect diagnosis of sexually transmitted disease infection in studies of condom effectiveness: a simulation-based assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578799" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15800269" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14742284" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16731685" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Condom effectiveness for prevention of C trachomatis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7709320" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Condom use to prevent incident STDs: the validity of self-reported condom use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23644282" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Condom use and human papillomavirus in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23002192" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23002192" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11916494" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Condom use and the prevention of genital herpes acquisition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16287791" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The relationship between condom use and herpes simplex virus acquisition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11427138" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/71612" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The condom and gonorrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1571382" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2324542" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9243745" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Clinical sexually transmitted diseases among human immunodeficiency virus-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9792391" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/707474" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11518896" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610697" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Re: Condom efficacy against gonorrhea and nongonococcal urethritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9518383" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9293607" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Risk factors for urethritis in heterosexual men. The role of fellatio and other sexual practices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14566832" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14566831" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The effectiveness of condoms for the prevention of sexually transmitted diseases</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19455075" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : A systematic review of epidemiologic studies assessing condom use and risk of syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23644283" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23644283" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2535978" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Mineral oil lubricants cause rapid deterioration of latex condoms.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
